TY - JOUR
KW - Humans
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Sweden/epidemiology
KW - Harm Reduction
KW - naloxone
KW - Needle Exchange Programs
KW - opioid substitution treatment
KW - Opioids
KW - overdose management
KW - Prevention programs
KW - substance use
AU - K. Troberg
AU - P. Isendahl
AU - M. A. Blomé
AU - D. Dahlman
AU - A. Hakansson
A1 - 
AD - Division of Psychiatry, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Malmö Addiction Centre, Region Skåne, Malmö, Sweden.; Department of Infectious Disease, University Hospital Skåne, Malmö, Sweden.; Department of Infectious Disease, University Hospital Skåne, Malmö, Sweden.; Regional Office for Communicable Disease Control, Malmö, Sweden.; Division of Psychiatry, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Region Skåne, Malmö, Sweden.; Division of Psychiatry, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Malmö Addiction Centre, Region Skåne, Malmö, Sweden.
BT - Frontiers in public health
C5 - Education & Workforce; Opioids & Substance Use
DO - 10.3389/fpubh.2022.811001
JF - Frontiers in public health
LA - eng
M1 - Journal Article
PB - Troberg, Isendahl, Blomé, Dahlman and Håkansson
PY - 2022
SN - 2296-2565; 2296-2565
SP - 811001
T1 - Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
T2 - Frontiers in public health
TI - Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
U1 - Education & Workforce; Opioids & Substance Use
U2 - 35359781
U3 - 10.3389/fpubh.2022.811001
VL - 10
VO - 2296-2565; 2296-2565
Y1 - 2022
Y2 - Mar 10
ER -